Cisterna Biologics
YC S22San Diego, US · Founded 2022 · 2 employees · 1 known investors
Cisterna Biologics develops yeast-engineered mRNA manufacturing technology that can be selectively purified to drive protein expression in human cells. The company targets cost-effective, scalable, and non-immunogenic mRNA production for therapeutic applications.
AI & Machine LearningBiotechDeep TechHealthtechSynthetic BiologyTherapeuticsin /cisterna-biologics/@CisternaBXycombinator.com ↗
Founders & leadership· Y Combinator alumni (S22)
HB
Hari BhaskaraninFounder
Investors · 1
In the news
- Cisterna Biologics Funding | Complete Analysis | Extruct AIextruct.ai · 2022
- Cisterna Biologics - High quality mRNA for therapeutic application 👩🏽🔬ycombinator.com · 2022